Jennifer K. Moses
2020
In 2020, Jennifer K. Moses earned a total compensation of $1.7M as Chief Financial Officer at G1 Therapeutics, a 18% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $141,050 |
|---|---|
| Option Awards | $1,116,239 |
| Salary | $398,583 |
| Other | $8,550 |
| Total | $1,664,422 |
Moses received $1.1M in option awards, accounting for 67% of the total pay in 2020.
Moses also received $141.1K in non-equity incentive plan, $398.6K in salary and $8.6K in other compensation.
Rankings
In 2020, Jennifer K. Moses' compensation ranked 6,371st out of 13,090 executives tracked by ExecPay. In other words, Moses earned more than 51.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,371 out of 13,090 | 51st |
Division Manufacturing | 2,627 out of 5,621 | 53rd |
Major group Chemicals And Allied Products | 1,059 out of 2,254 | 53rd |
Industry group Drugs | 915 out of 1,954 | 53rd |
Industry Pharmaceutical Preparations | 683 out of 1,459 | 53rd |
Source: SEC filing on April 28, 2021.
Moses' colleagues
We found five more compensation records of executives who worked with Jennifer K. Moses at G1 Therapeutics in 2020.